Carl Icahn’s Top 10 Hedge Fund Stock Holdings to Watch

As the Dow rebuilds to 11,038 and the S&P to 1,153 today, Wall St. Watchdog reveals information about Icahn Associates’ top 10 holdings:

  • Motorola Solutions, Inc. (NYSE:MSI): On 3/31/11 Icahn Associates reported holding 214,436,549 shares with a market value of $1,944,939,434. This comprised 34.57% of the total portfolio. On 6/30/11, Icahn Associates held 30,633,789 shares with a market value of $1,369,023,988. This comprised 21.95% of the total portfolio. The net change in shares for this position over the two quarters is -183,802,760. About the company: Motorola Solutions, Inc. manufactures two-way radios and accessories; mobile computers; wireless network infrastructure; private radio systems; bar code scanning and radio frequency identification equipment, and public safety broadband equipment.
  • Biogen Idec Inc. (NASDAQ:BIIB): On 3/31/11 Icahn Associates reported holding 12,860,205 shares with a market value of $862,276,784. This comprised 15.33% of the total portfolio. On 6/30/11, Icahn Associates held 12,860,205 shares with a market value of $944,839,277. This comprised 15.15% of the total portfolio. The net change in shares for this position over the two quarters is 0,000. About the company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Genzyme Corp. (NASDAQ:GENZ): On 3/31/11 Icahn Associates reported holding 10,480,000 shares with a market value of $746,175,968. This comprised 13.26% of the total portfolio. On 6/30/11, Icahn Associates held 10,480,000 shares with a market value of $798,052,016. This comprised 12.80% of the total portfolio. The net change in shares for this position over the two quarters is 0,000. About the company: Genzyme Corporation is a global biotechnology company that develops products for people with serious diseases. The Company focuses on developing therapeutics for rare disorders, renal diseases, orthopaedics, cancer, transplant and immune disease, and diagnostic and predictive testing. Genzyme also provides diagnostic products and services.
  • Clorox Corporation (NYSE:CLX): On 3/31/11 Icahn Associates reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Icahn Associates held 10,000,000 shares with a market value of $700,699,997. This comprised 11.24% of the total portfolio. The net change in shares for this position over the two quarters is 10,000,000. About the company: The Clorox Company produces and markets non-durable consumer products sold primarily through grocery and other retail stores. The Company’s principal products include household cleaning and bleach products, charcoal, cat litter, automotive care products, dressings, and trash bags. Clorox markets its products in the United States and other countries around the world.
  • Motorola Mobility Holdings (NYSE:MMI): On 3/31/11 Icahn Associates reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Icahn Associates held 26,804,565 shares with a market value of $654,031,376. This comprised 10.49% of the total portfolio. The net change in shares for this position over the two quarters is 26,804,565. About the company: Motorola Mobility Holdings Inc. provides advanced mobile media solutions and multi-screen technologies. The Company develops products that include consumer mobile phones, business-ready smartphones accessories, cordless phones, and home networking products.
  • Lions Gate Entertainment Corp. (NYSE:LGF): On 3/31/11 Icahn Associates reported holding 35,713,655 shares with a market value of $232,495,902. This comprised 4.13% of the total portfolio. On 6/30/11, Icahn Associates held 35,713,655 shares with a market value of $223,210,344. This comprised 3.58% of the total portfolio. The net change in shares for this position over the two quarters is 0,000. About the company: Lions Gate Entertainment Corp. develops, produces, and distributes filmed entertainment content. The Company’s divisions produce motion pictures, television programming, animation, and digital media. Lions Gate distributes its films and other media in the United States, Canada, and internationally.
  • Mentor Graphics Corp. (NASDAQ:MENT): On 3/31/11 Icahn Associates reported holding 12,896,232 shares with a market value of $154,754,784. This comprised 2.75% of the total portfolio. On 6/30/11, Icahn Associates held 12,896,232 shares with a market value of $188,671,876. This comprised 3.03% of the total portfolio. The net change in shares for this position over the two quarters is 0,000. About the company: Mentor Graphics Corporation manufactures, markets, and supports software and hardware electronic design automation products. The Company provides related services which enable engineers to design, analyze, simulate, model, implement, and verify the components of electronic systems.
  • The Hain Celestial Group, Inc. (NASDAQ:HAIN): On 3/31/11 Icahn Associates reported holding 5,351,331 shares with a market value of $144,807,014. This comprised 2.57% of the total portfolio. On 6/30/11, Icahn Associates held 5,704,451 shares with a market value of $184,139,671. This comprised 2.95% of the total portfolio. The net change in shares for this position over the two quarters is 353,120. About the company: The Hain Celestial Group, Inc. is a natural and organic beverage, snack, specialty food, and personal care products company. The Company’s product line include grocery store foods such as organic cookies, cooking oils, sugar free products, kosher foods, snacks, and frozen foods, as well as organic skin, hair, and body products. Hain Celestial sells and markets in North America and Europe.
  • Lawson Software, Inc. (NASDAQ:LWSN): On 3/31/11 Icahn Associates reported holding 13,581,946 shares with a market value of $125,633,001. This comprised 2.23% of the total portfolio. On 6/30/11, Icahn Associates held 14,278,916 shares with a market value of $172,774,889. This comprised 2.77% of the total portfolio. The net change in shares for this position over the two quarters is 696,970. About the company: Lawson Software, Inc. provides enterprise software solutions targeting specific services industries. The Company provides financial management, human resources, professional services automation, procurement, distribution, and customer relationship management solutions. Lawson has customers in the healthcare, retail, professional services, public sector, and other industries.
  • Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN): On 3/31/11 Icahn Associates reported holding 14,381,925 shares with a market value of $211,558,117. This comprised 3.76% of the total portfolio. On 6/30/11, Icahn Associates held 14,381,925 shares with a market value of $163,522,486. This comprised 2.62% of the total portfolio. The net change in shares for this position over the two quarters is 0,000. About the company: Amylin Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines for diabetes and obesity. The Company’s marketed products include treatments for adults with type 1 and type 2 diabetes.

(Note:  Data on the contents of the fund’s 13F filing are sourced from whalewisdom.com.  Positions in warrants, preferred shares, other convertible securities, puts, and calls are not considered.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Must read: World’s Worst Stock Picker? Here’s Carl Icahn’s 7 Worst Investments>>